On 5 June, the European Commission published a Commission Notice providing further clarity about the Packaging and Packaging Waste Regulation in practice. We take a closer look at the document to understand its requirements in detail, including the current status of PFAS restrictions, the…
In this Innovation Spotlight, Dow outlines how its extrusion coating portfolio aims to support recyclability requirements and regulatory readiness, and how its collaboration with RDM Group demonstrates how lightweight polymer coatings can extend the use of fibre-based packaging into applications…
Angus Freeman, head of packaging lifecycle management at GSK, discusses with Tim Sykes how serialisation looks in the context of one of the world’s largest pharmaceutical companies.
Crest Solutions partners with pharma companies across Europe to deliver and support solutions for serialisation and aggregation. The project manager from a recent collaboration in Ireland shares key practical takeaways from the experience
The costs of serialisation put focus on ROI. Tim Sykes spoke to Molteni's Tiziano Petrucciani about the company’s collaboration with Rockwell Automation, using serialisation as a springboard for modernisation of its manufacturing processes
Steve Wood, CEO of Covectra Inc, sets out his vision of an industry that harnesses serialisation to deliver better supply chain efficiency and patient outcomes.
At Pharmapack, LSS Labelling Systems Scandinavia will launch a new Tamper Evident labelling machine for the pharmaceutical industry at the Novexx Solutions booth (Paris, 2018, February, 7 – 8, Hall 7.1, D60).
As a leading Contract Development and Manufacturing Organisation, Recipharm has had to grapple with the demands of serialisation in terms of its own needs and those of its customers and their supply chains. Erik Haeffler speaks to Packaging Europe
At Pharmapack, LSS Labelling Systems Scandinavia will launch a new Tamper Evident labelling machine for the pharmaceutical industry at the Novexx Solutions booth (Paris, 2018, February, 7 – 8, Hall 7.1, D60).
The clock is ticking on the EU Falsified Medicines Directive. Are the pharma brand owners & CMOs ready? Beyond compliance, what is the industry making of the opportunities presented by serialisation? Five industry insiders share their insights.
Counterfeit pharma figures continue to grow due to increasingly complex supply chains, the increased sophistication of counterfeiters, a lack of enforcement capacity, and the expansion of e-commerce, writes Essentra's Rupert Taylor
